Global Allergy Immunotherapy Market Report 2024

Allergy Immunotherapy Global Market Report 2024 – By Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types), By Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)), By Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Allergy Immunotherapy Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Allergy Immunotherapy Market Definition And Segments

Allergy immunotherapy refers to a type of therapy used to avoid allergic reactions to things like house dust mites, grass pollen, and bee venom. Immunotherapy includes giving the patient increasingly higher dosages of the chemical or allergen they are allergic to.

The main allergy types in allergy immunotherapy are allergic rhinitis, asthma, food allergy, venom allergy, and others. Allergic rhinitis refers to a diagnosis connected to a collection of symptoms that affect the nose. The various treatments involved are immunotherapy (SCIT), sublingual immunotherapy and specific immunotherapy (SIT). The various channels include hospital pharmacy, retail pharmacy and online pharmacy.

The allergy immunotherapy market covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

The allergy immunotherapy market size has grown rapidly in recent years. It will grow from $2.59 billion in 2023 to $2.86 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing incidence of allergic diseases, advancements in immunotherapy techniques, growing awareness among patients, government initiatives, improvements in research and development.

The allergy immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $4.43 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to rising global allergy burden, healthcare policy support, increasing acceptance of immunotherapy, emerging markets and untapped regions, increasing healthcare expenditure. Major trends in the forecast period include advancements in treatment technology, increasing allergy prevalence, rise in patient awareness and education, telemedicine and remote monitoring, customized treatment plans.

Allergy Immunotherapy Market Surges With Growing Prevalence Of Allergic Disorders

The rising prevalence of allergic disorders is expected to propel the growth of the allergy immunotherapy market going forward. Allergic disorders refer to excessive immune responses to specific antigens. Immune responses that are inappropriately directed against intrinsic bodily parts (self) result in autoimmune diseases. Allergy immunotherapy is available to atopic people who have allergy disorders like IgE-mediated allergic rhinitis and allergic asthma brought on by inhaled allergens, including pollens and house dust mites (HDMs). For instance, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, in 2021, in the USA, nearly one-third of adults aged 18 and up suffered from a seasonal allergy, skin condition, or food allergy. Overall, seasonal allergy was the most common of the three allergies, with approximately one-quarter (25.7%) of adults diagnosed, and followed by eczema (7.3%) and food allergy (6.2%). Women were more likely than men to be allergic to all three allergens. Also, the prevalence of seasonal allergy diagnoses was 24.7% in adults aged 18–44, 27.9% in adults aged 45–64, 26.4% in adults aged 65–74, and 21.7% in adults aged 75 and up. Therefore, the rising prevalence of allergic disorders is driving the growth of the allergy immunotherapy market.

Alcohol Consumption Surge Propels Growth In Allergy Immunotherapy Market

The increasing consumption of alcohol is expected to propel the growth of the allergy immunotherapy market going forward. Alcohol refers specifically to ethyl alcohol or ethanol, psychoactive substance and consumption of alcoholic beverages have intoxicating effects which lead to health risks. Alcoholic drinks, such as red wine, contain histamine, which contributes to allergic-like symptoms, are treated using allergy immunotherapy. For instance, in December 2022, according to a report published by Kirin Holdings Company Limited, a Japan-based beverages company, about 185.60 million kiloliters of beer were consumed worldwide in 2021, a rise of 4.0% from the previous year. This is around 150 times as many as the Tokyo Dome could hold. Therefore, the increase in alcohol consumption is driving the growth of the allergy immunotherapy market.

Increasing Healthcare Expenditure Drives The Allergy Immunotherapy Market

The increasing healthcare expenditure is expected to propel the growth of the allergy immunotherapy market going forward. Increased healthcare expenditure often leads to heightened focus on innovative and effective treatment modalities, particularly for prevalent conditions like allergies. Allergy immunotherapy, with its potential to address the root causes of allergic diseases and offer sustained relief, is well-positioned to benefit from this increased financial commitment to healthcare. The expanding financial resources are likely to enhance accessibility to immunotherapy treatments, driving adoption rates and contributing to the overall market expansion. For example, in the Economic Survey of 2022, an annual document of the Ministry of Finance, Government of India, and India’s public expenditure on healthcare stood at 2.1% of GDP in 2021-22 against 1.8% in 2020-21. Moreover, according to a survey of global medical insurers conducted by Willis Towers Watson Public Limited Company, a British-American company providing insurance services, the healthcare benefit cost increased from 8.2% in 2021, to 8.8% in 2022, and is expected to grow again in 2023 to a high global average of 10%. Therefore, the increased healthcare expenditure will drive the growth of the allergy immunotherapy market during forecast period.

Major companies operating in the allergy immunotherapy market report are LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics PLC, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd. .

Artificial Intelligence (AI)-Powered Allergy Component Testing For Advanced Allergy Diagnosis

Major companies operating in the allergy immunotherapy market are innovating technological products, such as the artificial intelligence (AI)-powered allergy component testing, to sustain their position in the market. Artificial intelligence (AI)-powered allergy component testing is a novel testing platform based on Component Resolved Diagnostics (CRD) for diagnosing various forms of allergies. For instance, in May 2023, Metropolis Healthcare Limited, an Indian-based Medical laboratory company launched artificial intelligence (AI)-powered allergy component testing. Artificial intelligence (AI)-powered allergy component testing is a fourth-generation allergy testing technology that uses Artificial Intelligence (AI) to assist clinicians in making clinical decisions. It provides great insights, selecting, and optimizing the course of treatment for allergic diseases. It is also capable of predicting the effectiveness of immunotherapy for allergy vaccinations which are effective or not.

Strategic Partnerships To Expand Capabilities

Major companies operating in the allergy immunotherapy market are adopting a strategic partnership approach to expand their capabilities. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. In November 2022, Vimian Group AB, a Sweden-based veterinary company, entered into a partnership with Angany Inc., a Canada-based pharmaceutical company dedicated to allergy immunotherapy. With this partnership, Vimian Group AB aims to develop novel vaccines for allergy and atopic dermatitis in companion animals with proprietary eBioparticle-Potentiated Immunotherapy technology.

Europe was the largest region in the allergy immunotherapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the allergy immunotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The allergy immunotherapy market includes revenues earned by entities by providing monoclonal antibodies and immune checkpoint inhibitors therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The allergy immunotherapy market research report is one of a series of new reports from The Business Research Company that provides allergy immunotherapy market statistics, including the allergy immunotherapy industry global market size, regional shares, competitors with allergy immunotherapy market share, detailed allergy immunotherapy market segments, market trends, and opportunities, and any further data you may need to thrive in the allergy immunotherapy industry. This allergy immunotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Allergy Immunotherapy Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.86 billion
Revenue Forecast In 2033 $4.43 billion
Growth Rate CAGR of 11.6% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types
2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)
3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled LETI Pharma; Stallergenes Greer International AG; Allergy Therapeutics plc; ALK-Abelló A/S; HAL Allergy B.V.; DBV Technologies; Circassia Pharmaceuticals Inc.; Jubilant HollisterStier LLC; Allergopharma GmbH & Co. KG; Biomay AG; Anergis SA; HollisterStier Allergy; Mylan N.V.; Adamis Pharmaceuticals Corporation; Desentum Oy; WOLW Pharma Limited; AllerGenics Inc.; Greer Laboratories Inc.; Aimmune Therapeutics Inc.; Reliant Laboratories Inc.; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; Danaher Corporation; QIAGEN NV; Merck & Co. Inc.; Pfizer Inc.; Novartis AG; GlaxoSmithKline plc; AstraZeneca plc; Sanofi SA; Teva Pharmaceutical Industries Ltd.; Endo Pharmaceuticals Inc.; Sun Pharmaceutical Industries Ltd.; Cipla Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Allergy Immunotherapy Market Characteristics

    3. Allergy Immunotherapy Market Trends And Strategies

    4. Allergy Immunotherapy Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Allergy Immunotherapy Market Size and Growth

    5.1. Global Allergy Immunotherapy Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Allergy Immunotherapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Allergy Immunotherapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Allergy Immunotherapy Market Segmentation

    6.1. Global Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Allergic Rhinitis

    Asthma

    Food Allergy

    Venom Allergy

    Other Allergy Types

    6.2. Global Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Subcutaneous Immunotherapy (SCIT)

    Sublingual Immunotherapy

    Specific Immunotherapy (SIT)

    6.3. Global Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Online Pharmacy

    7. Allergy Immunotherapy Market Regional And Country Analysis

    7.1. Global Allergy Immunotherapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Allergy Immunotherapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Allergy Immunotherapy Market  

    8.1. Asia-Pacific Allergy Immunotherapy Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Allergy Immunotherapy Market  

    9.1. China Allergy Immunotherapy Market Overview  

    9.2. China Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Allergy Immunotherapy Market  

    10.1. India Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Allergy Immunotherapy Market  

    11.1. Japan Allergy Immunotherapy Market Overview  

    11.2. Japan Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Allergy Immunotherapy Market  

    12.1. Australia Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Allergy Immunotherapy Market  

    13.1. Indonesia Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Allergy Immunotherapy Market  

    14.1. South Korea Allergy Immunotherapy Market Overview  

    14.2. South Korea Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Allergy Immunotherapy Market  

    15.1. Western Europe Allergy Immunotherapy Market Overview

    15.2. Western Europe Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Allergy Immunotherapy Market  

    16.1. UK Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Allergy Immunotherapy Market  

    17.1. Germany Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Allergy Immunotherapy Market  

    18.5. France Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Allergy Immunotherapy Market  

    19.9. Italy Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Allergy Immunotherapy Market  

    20.13. Spain Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Allergy Immunotherapy Market  

    21.1. Eastern Europe Allergy Immunotherapy Market Overview

    21.2. Eastern Europe Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Allergy Immunotherapy Market  

    22.1. Russia Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Allergy Immunotherapy Market  

    23.1. North America Allergy Immunotherapy Market Overview

    23.2. North America Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Allergy Immunotherapy Market  

    24.1. USA Allergy Immunotherapy Market Overview

    24.2. USA Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Allergy Immunotherapy Market  

    25.1. Canada Allergy Immunotherapy Market Overview

    25.2. Canada Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Allergy Immunotherapy Market  

    26.1. South America Allergy Immunotherapy Market Overview

    26.2. South America Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Allergy Immunotherapy Market  

    27.1. Brazil Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Allergy Immunotherapy Market  

    28.1. Middle East Allergy Immunotherapy Market Overview

    28.2. Middle East Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Allergy Immunotherapy Market  

    29.1. Africa Allergy Immunotherapy Market Overview

    29.2. Africa Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Allergy Immunotherapy Market Competitive Landscape And Company Profiles

    30.1. Allergy Immunotherapy Market Competitive Landscape

    30.2. Allergy Immunotherapy Market Company Profiles

    30.2.1. LETI Pharma

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Stallergenes Greer International AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Allergy Therapeutics plc

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. ALK-Abelló A/S

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. HAL Allergy B.V.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Allergy Immunotherapy Market Competitive Benchmarking

    32. Global Allergy Immunotherapy Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Allergy Immunotherapy Market

    34. Allergy Immunotherapy Market Future Outlook and Potential Analysis

    34.1 Allergy Immunotherapy Market In 2028 - Countries Offering Most New Opportunities

    34.2 Allergy Immunotherapy Market In 2028 - Segments Offering Most New Opportunities

    34.3 Allergy Immunotherapy Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Allergy Immunotherapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Allergy Immunotherapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: LETI Pharma Financial Performance
  • Table 75: Stallergenes Greer International AG Financial Performance
  • Table 76: Allergy Therapeutics plc Financial Performance
  • Table 77: ALK-Abelló A/S Financial Performance
  • Table 78: HAL Allergy B.V. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Allergy Immunotherapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Allergy Immunotherapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: LETI Pharma Financial Performance
  • Figure 75: Stallergenes Greer International AG Financial Performance
  • Figure 76: Allergy Therapeutics plc Financial Performance
  • Figure 77: ALK-Abelló A/S Financial Performance
  • Figure 78: HAL Allergy B.V. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the allergy immunotherapy market?

Allergy immunotherapy refers to a type of therapy used to avoid allergic reactions to things like house dust mites, grass pollen, and bee venom. Immunotherapy includes giving the patient increasingly higher dosages of the chemical or allergen they are allergic to. For further insights on the allergy immunotherapy market, request a sample here

How will the allergy immunotherapy market drivers and restraints affect the allergy immunotherapy market dynamics? What forces will shape the allergy immunotherapy industry going forward?

The allergy immunotherapy market major growth driver - allergy immunotherapy market surges with growing prevalence of allergic disorders. For further insights on the allergy immunotherapy market, request a sample here

What is the forecast market size or the forecast market value of the allergy immunotherapy market ?

The allergy immunotherapy market size has grown rapidly in recent years. It will grow from $2.59 billion in 2023 to $2.86 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing incidence of allergic diseases, advancements in immunotherapy techniques, growing awareness among patients, government initiatives, improvements in research and development. The allergy immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $4.43 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to rising global allergy burden, healthcare policy support, increasing acceptance of immunotherapy, emerging markets and untapped regions, increasing healthcare expenditure. Major trends in the forecast period include advancements in treatment technology, increasing allergy prevalence, rise in patient awareness and education, telemedicine and remote monitoring, customized treatment plans. For further insights on the allergy immunotherapy market, request a sample here

How is the allergy immunotherapy market segmented?

The allergy immunotherapy market is segmented
1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types
2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)
3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online PharmacyFor further insights on the allergy immunotherapy market,
request a sample here

Which region has the largest share of the allergy immunotherapy market? What are the other regions covered in the report?

Europe was the largest region in the allergy immunotherapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the allergy immunotherapy market, request a sample here.

Who are the major players in the allergy immunotherapy market?

Major companies operating in the allergy immunotherapy market report are LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd. . For further insights on the allergy immunotherapy market, request a sample here.

What are the key trends in the allergy immunotherapy market?

Major trend in the allergy immunotherapy market - artificial intelligence (ai)-powered allergy component testing for advanced allergy diagnosis. For further insights on the allergy immunotherapy market, request a sample here.

What are the major opportunities in the allergy immunotherapy market? What are the strategies for the allergy immunotherapy market?

For detailed insights on the major opportunities and strategies in the allergy immunotherapy market, request a sample here.

How does the allergy immunotherapy market relate to the overall economy and other similar markets?

For detailed insights on allergy immunotherapy market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the allergy immunotherapy industry?

For detailed insights on the mergers and acquisitions in the allergy immunotherapy industry, request a sample here.

What are the key dynamics influencing the allergy immunotherapy market growth? SWOT analysis of the allergy immunotherapy market.

For detailed insights on the key dynamics influencing the allergy immunotherapy market growth and SWOT analysis of the allergy immunotherapy industry, request a sample here.